We are live on ! Find out more
WGBS

WaferGen Bio-systems, Inc.
WGBS

Delisted

WGBS was delisted on the 28th of February, 2017.

0 hedge funds and large institutions have $0 invested in WaferGen Bio-systems, Inc. in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 90 (-9)

100% less capital invested

Capital invested by funds: $3.59M → $0 (-$3.59M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
Holders Change
-9
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
-$1.77M -358,535 Closed
OM
2
Opaleye Management
Massachusetts
-$1.58M -320,000 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
-$104K -21,088 Closed
Creative Planning
4
Creative Planning
Kansas
-$103K -20,861 Closed
UBS Group
5
UBS Group
Switzerland
-$31K -6,287 Closed

WGBS Hedge Fund Activity: Q1 2017 in Review

0 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in WaferGen Bio-systems, Inc. (WGBS) for Q1 2017, worth a combined $0 — down 100% from $3.59M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of WGBS and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $1.77M sold.

  • 0 institutional investors held WaferGen Bio-systems, Inc. (WGBS) as of Q1 2017, down from 9 in Q4 2016.
  • Funds reported $0 of WaferGen Bio-systems, Inc. stock for Q1 2017, down 100% quarter-over-quarter.
  • 0 funds opened new WaferGen Bio-systems, Inc. positions in Q1 2017 and 8 closed out, a net change of -8 holders.
  • The largest WaferGen Bio-systems, Inc. seller in Q1 2017 was Sabby Management, an estimated $1.77M sold.

Based on aggregated 13F filings for Q1 2017.